Man Group PLC Genfit S.A. Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$14.92 - $19.94 $468,488 - $626,116	-31,400 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$19.74 - $25.65 $2.97 Million - $3.86 Million	-150,481 Reduced 82.74%	31,400 $620,000
Q1 2019 May 15, 2019	BUY	$22.17 - $24.0 $4.03 Million - $4.37 Million	181,881 New	181,881 $4.37 Million

77.7K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $209M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.